Drug Profile
Allergy vaccine - Acambis
Alternative Names: Antiallergy vaccine - AcambisLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator University of Birmingham
- Class Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Food hypersensitivity; Seasonal allergic rhinitis
Most Recent Events
- 23 Jul 1999 Discontinued-I for Seasonal allergic rhinitis in Poland (Unknown route)
- 23 Jul 1999 Discontinued-II for Food allergy in Poland (Unknown route)
- 26 Feb 1998 Phase-I clinical trials for Seasonal allergic rhinitis in Poland (Unknown route)